Ten-year clinical trial report finds radiation comparable to surgery for early-stage non-small cell lung cancer
SAN FRANCISCO, September 29, 2025 — A new clinical trial report finds that stereotactic radiation therapy offers long-term survival outcomes comparable to surgery for patients with small, early-stage non-small cell lung cancer (NSCLC). Patients in the study who received radiation also reported fewer side effects after treatment.
The STARS trial (NCT02357992) is the first to report ten-year clinical outcomes from a prospective comparison of stereotactic radiation and surgical resection for operable NSCLC. Findings will be presented ...